We are monitoring the impact of COVID-19 on APAC Drug Delivery Devices Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2254
Share on
Share on

Asia Pacific Drug Delivery Devices Market Research Report – Segmented By Route of Administration, By Facility of Use, By Country (India, China, Japan, Australia, South Korea and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2020 to 2025)

Pulished: February, 2020
ID: 2254
Pages: 180

APAC Drug Delivery Devices Market Size (2020 to 2025)

The Drug Delivery Devices Market size in the Asia Pacific region was valued at USD 214.36 Million in 2020 and is expected to be USD 302.05 Million by 2025, growing at a CAGR of 7.1% during the forecast period.

There are many growth contributing factors responsible for market growth in terms of the drug delivery devices market. Drug delivery devices are medical equipment used for introducing a drug into human bodies and various systems in human bodies. Various routes of administration techniques do the administration of a drug into human bodies. Factors such as an increase in the prevalence of chronic diseases, the spread of infections, increased population where the pediatric and geriatric ratio contributes to the market's growth. Other factors, such as the increased adaption of therapeutic medicines and surgeries, increased awareness of early detection of diseases, and treatment, also increase the market growth. These devices are most often therapeutically used. Developed research activities across the country, technological advancements are observed in the forecast period and are major market drivers. Government initiatives towards creating awareness in public about early detection of diseases and its treatment, fundraisings from NGOs, and the public drive growth for this market.  

For handling and associating with these devices and equipment, a lot of caring and staff are required. Skilled persons, professionals are always needed to carry out these processes. Increased complications associated with delivering and manufacturing medicines hamper the market growth. Administrating selected drugs to targeted sites is hard to achieve. There are also a lot of safety concerns with this market. There are stringent regulations, and the approval committee for providing grants for these devices makes this market more challenging to achieve its goals.

This research report on the Asia-Pacific Drug Delivery Devices Market has been segmented and sub-segmented into the following categories:

  • By Route of Administration: Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Tran mucosal Drug Delivery.
  • By End-User: Hospitals, Ambulatory Surgical Centers, Home Care settings, Diagnostic Centers.
  • By Region: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and Rest of APAC

Regional Analysis: 

The Asia Pacific expects the highest market growth during the forecast period. China and Japan regions are noted as highly populated across Asia pacific. Hence the rise in populations leads to demand for the availability of drugs and drug-delivering devices. In regions like India, the government has brought up many initiatives to support health care and patient safety. It raises awareness in the public about the early detection of diseases and their treatment. Hence the drug administration process is monetarily done. Increased technological developments, research activities, rise in investors, and public funders for this market, increased demand for pharmaceutical industries contribute to the growth of the drug delivery devices market in the Asia Pacific region. 

Some of the Prominent Companies leading the Asia-Pacific Drug Delivery Devices Market Profiled in the Report are Bend Research, Endocyte, Microchips Inc., Pearl Therapeutics Inc., Presage Bioscience, UCB Group, Genentech Inc., Polymer Factory, Alkermes Inc., BIND Biosciences Inc., and QLT Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Route of administration                        

                                5.1.1 Introduction           

                                5.1.2 Oral Drug Delivery

                                5.1.3 Pulmonary Drug Delivery  

                                5.1.4 Inject able Drug Delivery   

                                5.1.5 Ocular Drug Delivery           

                                5.1.6 Nasal Drug Delivery             

                                5.1.7 Topical Drug Delivery          

                                5.1.8 Implantable Drug Delivery                

                                5.1.9 Tran mucosal Drug Delivery             

                                5.1.10  Y-o-Y Growth Analysis, By Route of administration            

                                5.1.11  Market Attractiveness Analysis, By Route of administration          

                                5.1.12  Market Share Analysis, By Route of administration            

                5.2 Facility of use                             

                                5.2.1 Introduction           

                                5.2.2 Hospitals  

                                5.2.3 Ambulatory Surgical Centers           

                                5.2.4 Home care settings             

                                5.2.5 Diagnostic Centers               

                                5.2.6 Others      

                                5.2.7 Y-o-Y Growth Analysis, By Facility of use    

                                5.2.8 Market Attractiveness Analysis, By Facility of use  

                                5.2.9 Market Share Analysis, By Facility of use    

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 Route of administration

                                                6.1.3.3 By Facility of use

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Route of administration

                                                6.1.4.3 By Facility of use

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Route of administration

                                                6.1.5.3 By Facility of use

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Bend Research                          

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Endocyte                     

                8.3 MicroCHIPS Inc                         

                8.4 Pearl Therapeutics Inc                           

                8.5 Presage Bioscience                 

                8.6 UCB Group                 

                8.7 Genentech Inc                          

                8.8 Polymer Factory                       

                8.9 Alkermes Inc                              

                8.10 BIND Biosciences Inc                            

                8.11 QLT Inc                       

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organisations a strong financial foothold in the market
  1. Asia-Pacific Drug Delivery Devices Market, By Route of administration, From 2020 to 2025 (USD Million)
  2. Asia-Pacific Oral Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  3. Asia-Pacific Pulmonary Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  4. Asia-Pacific Injectable Drug Delivery  Market, By Region, From 2020 to 2025 (USD Million)
  5. Asia-Pacific Ocular Drug Delivery  Market, By Region, From 2020 to 2025 (USD Million)
  6. Asia-Pacific Nasal Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  7. Asia-Pacific Topical Drug Delivery  Market, By Region, From 2020 to 2025 (USD Million)
  8. Asia-Pacific Implantable Drug Delivery  Market, By Region, From 2020 to 2025 (USD Million)
  9. Asia-Pacific Tran mucosal Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  10. Asia-Pacific Drug Delivery Devices Market, By Facility of use, From 2020 to 2025 (USD Million)
  11. Asia-Pacific Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  12. Asia-Pacific Ambulatory Surgical Centers Market, By Region, From 2020 to 2025 (USD Million)
  13. Asia-Pacific Home Care settings Market, By Region, From 2020 to 2025 (USD Million)
  14. Asia-Pacific Diagnostic Centers Market, By Region, From 2020 to 2025 (USD Million)
  15. Asia-Pacific Others Market, By Region, From 2020 to 2025 (USD Million)
  16. Japan Drug Delivery Devices Market, By Route of administration, From 2020 to 2025 (USD Million)
  17. Japan Drug Delivery Devices Market, By Facility of use, From 2020 to 2025 (USD Million)
  18. China Drug Delivery Devices Market, By Route of administration, From 2020 to 2025 (USD Million)
  19. China Drug Delivery Devices Market, By Facility of use, From 2020 to 2025 (USD Million)
  20. India Drug Delivery Devices Market, By Route of administration, From 2020 to 2025 (USD Million)
  21. India Drug Delivery Devices Market, By Facility of use, From 2020 to 2025 (USD Million)
  22. Australia Drug Delivery Devices Market, By Route of administration, From 2020 to 2025 (USD Million)
  23. Australia Drug Delivery Devices Market, By Facility of use, From 2020 to 2025 (USD Million)
  24. South Korea Drug Delivery Devices Market, By Route of administration, From 2020 to 2025 (USD Million)
  25. South Korea Drug Delivery Devices Market, By Facility of use, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample